Hacarus Inc.

In 2023 HACARUS launched “Cal.Liver.Lesion“ (an on-premise image analysis software that utilizes jointly developed AI with Bayer Yakuhin, which holds exclusive marketing rights for Cal.Liver.Lesion) and “HACARUS MD for Colposcopy” (an AI software that simplifies the storage, processing and recording of images for colposcopy using a colposcope (an instrument with a magnifying lens and a light) in response to the increasing importance of cervical cancer screening).